Centro de Atención e Investigación Cardiovascular del Potosí S.C.
Centro de Atención e Investigación Cardiovascular del Potosí S.C.
Hospital Ángeles, Antonio Aguilar 155-Piso 1 Int. L, Burocratas del Estado, 78213 San Luis Potosí, S.L.P., Mexico
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
José Luis Arenas León
Yunnen Castro
Victor Dimas
Rosario Aguilar
Maria Rivera Arellano
Andrea Arenas
Open studies
Lung cancer
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007) - MK 2870-007 - Merck Sharp & Dohme LLCSee more
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007) - MK 2870-007 - Merck Sharp & Dohme LLCSee more
Heart failure
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation - HERMES - Novo Nordisk A/SSee more
Inflammation
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation - HERMES - Novo Nordisk A/SSee more
